Infección por "mycobacterium tuberculosis"
- Fortún Abete, Jesús
- Martín Dávila, Pilar
- Rodríguez, J. M.
- Navas Elorza, Enrique
- Moreno Guillén, Santiago
ISSN: 0304-5412
Argitalpen urtea: 2010
Zenbakien izenburua: Enfermedades infecciosas (VIII): brucelosis, tuberculosis, infección por "legionella", mycoplasma" y "chlamidia"
Saila: 10
Zenbakia: 56
Orrialdeak: 3808-3819
Mota: Artikulua
Beste argitalpen batzuk: Medicine: Programa de Formación Médica Continuada Acreditado
Finantzaketari buruzko informazioa
167 4 2003 603 662 16. American Thoracic Society; Centers for Disease Control and Prevention; Infectious Diseases Society of America. American Thoracic Society/Centers for Disease Control and Prevention/Infectious Diseases Society of America: controlling tuberculosis in the United States. Am J Respir Crit Care Med. 2005;172(9):1169-227. 17. Five-year follow-up of a controlled trial of five 6-month regimens of chemotherapy for pulmonary tuberculosis. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis. 1987; 136(6):1339-42. 18. Controlled trial of 2, 4, and 6 months of pyrazinamide in 6-month, threetimes- weekly regimens for smear-positive pulmonary tuberculosis, including an assessment of a combined preparation of isoniazid, rifampin, and pyrazinamide. Results at 30 months. Hong Kong Chest Service/British Medical Research Council. Am Rev Respir Dis. 1991; 143(4):700-6. 19. J.E. Kaplan C. Benson K.H. Holmes J.T. Brooks A. Pau H. MasurFinantzatzaile
- National Institutes of Health United States
- Centers for Disease Control and Prevention United States
- Infectious Diseases Society of America United States